Tirzepatide Nausea: How Common, How Long It Lasts
Yes. Nausea is listed in 2 of 2 tirzepatide labels. The highest rate in each label runs from 18% on Mounjaro to 29% on Zepbound. Placebo in the Zepbound trials: 8%. Smaller, slower meals help most.
- Labels that list it
- 2 of 2
- Highest rate
- 29% Zepbound
- Lowest rate
- 18% Mounjaro
Zepbound facts at a glance
Its half-life is 5 to 6 days: after 5.5 d, half is gone, and about 3% remains after five half-lives (27.5 d).
After 72 weeks, SURMOUNT-1 found weight loss of 20.9% of body weight, compared with 3.1% on placebo.
Monthly prices in US dollars include the list price and self-pay offers, with each amount taken from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
Tirzepatide compared with placebo: how often it occurs
In the label trials, Tirzepatide nausea rates are broken down by dose group. In the same trial, the comparison group is the placebo group.
| Medicine and dose | Nausea | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Mounjaro 5 mg | 12% | 4% | +8 points | Adults with type 2 diabetes |
| Mounjaro 10 mg | 15% | 4% | +11 points | Adults with type 2 diabetes |
| Mounjaro 15 mg | 18% | 4% | +14 points | Adults with type 2 diabetes |
| Zepbound 5 mg | 25% | 8% | +17 points | Adults with obesity or overweight (weight management) |
| Zepbound 10 mg | 29% | 8% | +21 points | Adults with obesity or overweight (weight management) |
| Zepbound 15 mg | 28% | 8% | +20 points | Adults with obesity or overweight (weight management) |
Sources: Mounjaro label (DailyMed), Zepbound label (DailyMed).
Nausea: tirzepatide vs other GLP-1s
Every label provides results from its own trials, which involved different groups of people. Treat it as a rough guide.
Pill forms included in the table are Rybelsus and Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| 44% | 2.4 mg | 16% | Adults with obesity or overweight (weight management) | |
| Byetta | 44% | all doses | 18% | Adults with type 2 diabetes |
| 39.3% | all doses | 13.8% | Adults with obesity or overweight (weight management) | |
| 35% | 17.2 mg | 10% | Adults with obesity or overweight (weight management) | |
| 29% | 10 mg | 8% | Adults with obesity or overweight (weight management) | |
| 21.1% | 1.5 mg | 5.3% | Adults with type 2 diabetes | |
| 20.3% | 1 mg | 6.1% | Adults with type 2 diabetes | |
| 20% | 14 mg | 6% | Adults with type 2 diabetes | |
| 20% | 1.8 mg | 5% | Adults with type 2 diabetes | |
| 18% | 15 mg | 4% | Adults with type 2 diabetes |
Sources: Ozempic label (DailyMed), Wegovy label (DailyMed), Rybelsus label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
From the FDA label (DailyMed).
Why it happens on tirzepatide
These medicines reduce the speed at which your stomach empties. Nausea can come from food sitting longer, and it happens most often after big or fatty meals.
Source: health.clevelandclinic.org.
Description in the Mounjaro label
The label says the following about nausea, word for word:
“which may include persistent or severe abdominal pain (sometimes radiating to the back) and which may or may not be accompanied by nausea or vomiting.”
From the FDA label (DailyMed).
What helps, step by step
- Sip ginger or peppermint tea without any sweetener.
- After a meal, remain upright instead of lying down.
- Ask your prescriber about nausea medicine you could keep nearby
- Keep meals small and, once full, stop eating These medicines slow down how quickly your stomach empties.
- Eat slowly. Your brain needs time to register that you are full.
- Reduce fatty, greasy and sugary foods, which often cause symptoms.
- Let your prescriber know if it does not ease They may slow the pace of dose increases or suggest another GLP-1.
Before taking any product from the drugstore, check it with the GLP-1 interaction checker
Source: health.clevelandclinic.org.